Patents (Details Narrative) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Patent filing costs | $ 200,000 | $ 200,000 |
| Total investment in patents | 1,800,000 | 1,600,000 |
| Amortization expense of patents | $ 0 | $ 0 |
| Joint Venture Operating Agreement [Member] | Framatome [Member] | Maximum [Member] | ||
| Patents estimated useful life | 20 years | |
| Joint Venture Operating Agreement [Member] | Framatome [Member] | Minimum [Member] | ||
| Patents estimated useful life | 17 years | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|